ÂÜÀòÂÒÂ×

Dr. Oscar Alejandro Mesa Zapata serves as the Senior Global Director for Health Economics and Outcomes Research at Mallinckrodt Pharmaceuticals, focusing on the development of HEOR functions and evidence generation plans based on real-world evidence. With extensive experience in health economics and market access across various organizations, including Therakos and ViiV Healthcare, Dr. Mesa Zapata has successfully driven reimbursement submissions and positive health technology assessments in multiple countries. Educated at prestigious institutions such as the University of Oxford and Universidad Pontificia Bolivariana, Dr. Mesa Zapata holds various qualifications in health economics, public health, and business administration, alongside a medical degree.